Phase II clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non-small-cell lung cancer. (Q30979998)
scientific article
Language:
(P31) (Q13442814)
(P304) S20-3
(P407) (Q1860)
(P478) 6 Suppl 1
(P577) Wednesday, December 1, 2004
(P921) (Q42824440)
(Q418369)
(P1433) (Q332299)
(P1476) "Phase II clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non-small-cell lung cancer" (language: en)
(P2093) Roman Perez-Soler
other details
description scientific article

External Links